With 2023 poised to be the year of the adalimumab (Humira, AbbVie) biosimilar wave, a new report focuses on market expansion and sustainability for biosimilars in the United States. According to the report, issued by Cardinal Health, gastroenterologists appeared to be comfortable with the prospect of prescribing a Humira biosimilar, with 93% saying they were at least somewhat comfortable and 50% very comfortable. Safety and efficacy as well as overall issues with switching were the most often cited concerns. The first adalimumab biosimilar, adalimumab-atto (Amjevita, Amgen), entered the U.S. market on Jan. 31, after six years of regulatory delay. At…
Author: Abhay Panchal
The controversial prior authorization policy for colonoscopies that UnitedHealthcare wanted to put into effect today will not take place, the company said last night in a statement. Instead UHC wants to implement an alternative advance notification process that would require physicians to collect and submit patient data before performing non-screening and nonemergent colonoscopies, capsule endoscopis and esophagogastroduodenoscopies. That doesn’t settle the matter and in fact could be interpreted as being more ominous to patients and the physicians who perform colonoscopies, Barbara H. Jung, M.D., the president of the American Gastroenterological Association (AGA), said in a statement last night.
As I leave a conference organized for a group of physician entrepreneurs, I have so many thoughts running through my head. Some of these thoughts revolve around making my small, fledgling medical practice run more smoothly, reaching more people (and serving them better), and always remembering my why. These are the “business mastermind” skills I signed up to learn at the conference. But I may have come out of this with something way more valuable in the long run. I was also reminded of why I left what I was doing before and why I am continuing to follow this…
In 1988, President Ronal Reagan declared May National Digestive Diseases Awareness Month, and since then activities and programs have been implemented to increase the understanding of causes and treatments for various digestive diseases. The World Gastroenterology Organization celebrates World Digestive Health Day on May 29. The focus of this year’s campaign is “Your Digestive Health: A Healthy Gut from the Start,” which highlights that the gastrointestinal tract promotes organ function from the time of birth through the rest of our lives. The campaign seeks to help individuals better understand the GI tract’s normal function, importance of diet and when to…
Key takeaways: Most medical practices subject to data security regulations of the HIPAA Security Rule have adopted administrative, physical and technical safeguards for electronic protected health information in accordance with the HIPAA Security Rule.
Dr. Mark Pimentel discusses the emerging science of blood and breath testing in IBS and SIBO.
An unexplained rise in colorectal cancer rates among younger adults is leading more people – including physicians – to get screened for the disease early, sometimes far ahead of the recommended age of 45 for those at average risk. Scientists racing to find clues toward understanding why cases of colorectal cancer are climbing among younger people. Some suspect factors driving this increase are environmental, while others wonder if they are dietary. One new study, to be presented at the annual meeting of the American Society of Clinical Oncology in June, suggests that a young adult’s microbiome – the collection of…
A new screening test can detect colorectal cancer with a simple blood draw in people with an average risk of the cancer. The test can detect early-stage colorectal cancer with a sensitivity of 93%, according to mid-stage data shared by the test maker, Universal DX, in May. The test can also detect the pre-cancerous growths with 54% sensitivity. Colonoscopies are the gold standard for colorectal cancer screening. Not only can a provider find and diagnose cancerous growths, but they can also remove pre-cancerous polyps.
TORONTO, June 1, 2023 /CNW/ – Takeda Canada Inc. (“Takeda”) is pleased to announce the launch of the Takeda Canada Digital Health Innovation Challenge, an initiative to identify disruptive digital health solutions and explore new partnerships to accelerate and transform patient care in Canada. In the second challenge, Takeda is collaborating with Plug and Play Alberta (“Plug and Play”) to help broaden our reach and to harness their expertise in connecting innovative tech initiatives with large corporations to propel digital transformation.